Repligen (RGEN) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.34% |
| Dec 31, 2025 | 12.74% |
| Sep 30, 2025 | 14.95% |
| Jun 30, 2025 | 15.83% |
| Mar 31, 2025 | 17.33% |
| Dec 31, 2024 | 19.25% |
| Sep 30, 2024 | 17.40% |
| Jun 30, 2024 | 17.58% |
| Mar 31, 2024 | 20.36% |
| Dec 31, 2023 | 26.25% |
| Sep 30, 2023 | 23.31% |
| Jun 30, 2023 | 27.24% |
| Mar 31, 2023 | -17.34% |
| Dec 31, 2022 | 35.03% |
| Sep 30, 2022 | 40.57% |
| Jun 30, 2022 | 44.94% |
| Mar 31, 2022 | 46.50% |
| Dec 31, 2021 | 48.76% |
| Sep 30, 2021 | 48.50% |
| Jun 30, 2021 | 41.07% |
| Mar 31, 2021 | 41.60% |
| Dec 31, 2020 | 38.33% |
| Sep 30, 2020 | 36.55% |
| Jun 30, 2020 | 32.45% |
| Mar 31, 2020 | 29.59% |
| Dec 31, 2019 | 33.49% |
| Sep 30, 2019 | 35.37% |
| Jun 30, 2019 | 35.37% |
| Mar 31, 2019 | 33.43% |
| Dec 31, 2018 | 38.08% |
| Sep 30, 2018 | 21.35% |
| Jun 30, 2018 | 29.68% |
| Mar 31, 2018 | 30.30% |
| Dec 31, 2017 | 33.78% |
| Sep 30, 2017 | 26.88% |
| Jun 30, 2017 | 15.89% |
| Sep 30, 2016 | 23.38% |
| Jun 30, 2016 | 30.68% |
| Mar 31, 2016 | 33.55% |
| Dec 31, 2015 | 11.05% |
| Sep 30, 2015 | 22.08% |
| Jun 30, 2015 | 38.12% |